06/01/2026
We are delighted to announce the publication of the STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease 🎉
See the trial protocol here: https://bmjopen.bmj.com/content/15/12/e107597.full